A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors
Phillip L.R. Nicolson, John D. Welsh, Abhishek Chauhan, Mark R. Thomas, Mark L. Kahn, Steve P. Watson
Abstract
TEST 02 - Elsevier's Scopus, the largest abstract and citation database of peer-reviewed literature. Search and access research from the science, technology, medicine, social sciences and arts and humanities fields.
Topics & Concepts
Institutional review boardCoronavirus disease 2019 (COVID-19)MedicineIbrutinibDasatinibClinical trialSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Editorial board2019-20 coronavirus outbreakTranslational researchMedical physicsInternal medicineLibrary scienceSurgeryPathologyComputer scienceDiseaseReceptorLeukemiaChronic lymphocytic leukemiaInfectious disease (medical specialty)Tyrosine kinaseOutbreakChronic Lymphocytic Leukemia ResearchPlatelet Disorders and TreatmentsPhagocytosis and Immune Regulation